Chris Huang

About Chris Huang

Applying extensive pharmaceutical development experience, deep immunology and oncology disease expertise, strong analytic skills and project leadership to medical innovationsSUMMARY OF QUALIFICATIONS - 20+ years of experience in developing and implementing translational strategies by building large patient cohorts, generating genetics/genomics/transcriptomic/proteomics/immune profiling data, and applying computational technologies for indication selection, patient stratification, targetable pathways, drug differentiation, mechanisms of drug response and resistance in inflammatory, autoimmune and hematological malignancies- Experienced Translational Development /Biomarker Lead on compound development teams, crafted and implemented TD/BM strategies for early development programs; contributed to indication selection decisions and clinical trial design, protocol development and assay development. Led biomarker data analysis and authored biomarker reports to support regulatory submission- Demonstrated scientific excellence through 30+ publications in peer-reviewed scientific journals since joining pharma industry; 3 US/International patents; and directly contribution to 3 New Drug Application (NDA) – Bortezomib in Multiple Myeloma, Ustekinumab in Psoriasis, and Sirukumab in Rheumatoid Arthritis- A track record of fostering and managing external collaborations - partnered with thought leaders/KOLs, CROs and technology innovators that delivered innovative solutions- Seasoned people manager and cross-functional team leader, mentored junior scientists, postdocs, graduate students, and interns. Strength and Competencies- Effective Communication – ability to build trust with team and elaborate complex ideals and garner support from stakeholders- Execution excellence - skilled at business planning, resource forecasting, and monitoring team performance to ensure business timelines are always met- Creative thinking/risk taking - track record of initiating and piloting scientific programs with novelty

Experience

1. Director, Translational Medicine & Hematology Disease Strategy

   Bristol Myers Squibb

   Nov 2019 — Present

Education

• University of Science and Technology of China

  MS, Molecular Biology

• Stony Brook University

  Doctor of Philosophy - PhD, Genetics

• Stony Brook University

  PhD, Genetics

Skills

• Biological Data Analysis
• Molecular Biology
• Drug Discovery
• Cell Biology
• Clinical Trials
• Pharmaceutical Industry
• Cell
• Sequencing
• High Throughput Screening
• Translational Medicine
• Biomarker Discovery
• Personalized Medicine
• Biomarkers
• Oncology
• Computational Biology
• Nextgen Sequencing
• Genetics
• Proteomics
• Bioinformatics
• Strategic Partnerships
• Pharmacogenetics
• Genomics
• Gene Expression
• Antibodies
• Translational Research
• Human Genetics
• Clinical Research
• Drug Development
• Systems Biology
• Immunology